US approves first RSV vaccine during pregnancy to protect infants

US approves first RSV vaccine during pregnancy to protect infants

Daily Current Affairs / US approves first RSV vaccine during pregnancy to protect infants

Change Language English Hindi

Category : International Published on: August 23 2023

Share on facebook

The US Food and Drug Administration (FDA) on 21 August 2023, approved the first vaccine that protects newborns from Respiratory Syncytial Virus (RSV).
The vaccine is given to mothers late in their pregnancies and provides protection to infants through their first six months of life.
The approval allows the vaccine to be given to women 32 to 36 weeks into a pregnancy to prevent lower respiratory tract infection and severe disease in infants until they are six months old.
RSV is a common respiratory virus that usually causes mild, cold-like symptoms but can also lead to serious illness and hospitalisation.
The vaccine, sold under the brand name Abrysvo, is already approved for use in adults aged 60 and older to block infection from the disease that kills an estimated 1,60,000 people globally each year.

Recent Post's

Egypt discovers a new natural gas field in the Western Desert, boosting its energy reserves and export potential.
Read More....
9-year-old Arshi Gupta becomes India’s first female national karting champion, making history in the 2025 FMSCI National Karting Championship.
Read More....
COP30 2025 begins in Belem, Brazil, focusing on climate action, Paris Agreement implementation, forest protection and global climate finance.
Read More....
National Education Day 2025 celebrates Maulana Abul Kalam Azad’s vision of inclusive, modern, and quality education for all.
Read More....
India’s new deep-sea fishing rules aim to empower local fishermen, ban foreign vessels, and promote sustainable, tech-driven marine resource management.
Read More....
Mumbai tops Asia’s Happiest Cities 2025 list, reflecting its joyful spirit, community warmth, and lively street culture.
Read More....
Eli Lilly’s Mounjaro becomes India’s top-selling drug in October 2025 with ₹100 crore sales, revolutionizing diabetes and obesity management.
Read More....
UN Security Council lifts sanctions on Syrian President ahead of historic White House visit.
Read More....
Mizoram to host the “Mizoram Tourism Conclave” in collaboration with NITI Aayog to boost sustainable tourism and local livelihoods in the Northeast.
Read More....
Samrat Rana makes history as India’s first world champion in the men’s 10m air pistol event at the 2025 ISSF World Championship in Cairo.
Read More....